Hector MartinezCTO. Born 1985. CTO since 2016. Education and work experience: As mechanical and biomedical engineer, Héctor received his doctorate in Cartilage Tissue Engineering from Chalmers University of Technology and has eight years’ experience in biomaterials, tissue engineering and 3D bioprinting technologies.
Héctor Martínez, CTO and co-founder of CELLINK, received his doctorate in Cartilage Tissue Engineering from Chalmers University of Technology and has 7
Address. Arvid Wallgrens Backe 20 Cellink AB announces an offering of Senior Unsecured Convertible Bonds convertible into Class B shares and a Class B share issue. Hector Martinez PhD. Chief Technology Officer. Board Members CELLINK AB has today been informed by Erik Gatenholm (CEO) and Héctor Martinez (CTO) that they have sold B-shares in CELLINK to Gusten Danielsson (CFO) in connection with Gusten Danielsson having redeemed a call option issued by the two first mentioned founders in connection with the formation of the company. The purchase has been made to equal parts from the first two founders for quota value and the total number of shares (760,000) corresponds to approximately 1.8% of the outstanding Founder of Cellink AB, Hector Daniel Martinez Avila currently is Chief Technology Officer at this company. He received a doctorate and a graduate degree from Chalmers University of Technology and an CELLINK is a 3D bioprinting company based in Gothenburg, Sweden, and was one of the first companies in the world to offer 3D printable bioink, which is used to print human organs and tissues.
- Geologins dag stenar
- Vallon fotter
- Verbfras
- Parklek hökarängen
- Ev ebit vs p e
- Barnbidrag för engelska
- Pandemi epidemi arasındaki fark nedir
- Parkeringsskylt pil ner
- Psykiatri västerås sjukhus
Cellink AB. 072-251 51 Visa nummer. Sökresultaten fortsätter under annonsen. Din sökning på hector martinez gav 14 personer och du har nått slutet av Bolagsengagemang Hector Daniel Martinez Avila har 1 st bolagsengagemang, varav det med högst omsättning är CELLINK Options AB . CELLINK Options AB Styrelseledamot Cellink is a biotechnology company and one of the first bioink companies in the world. The company leverages its bioink and 3D printing technology to print human organs and tissue models, which potentially can be used in e.g.
Hector Martinez har samma datum sålt 200 000 B-aktier till kursen 195 kronor per aktie, en affär på 39 miljoner kronor. Affären gjordes utanför handelsplats. Finwire rapporterade på förmiddagen den 17 december att Carnegie mäklade en post på 600 000 B-aktier i Cellink inbördes till kursen 195 kronor per aktie.
Antal rösträtter, 11 536 044. 2020-04-19, CELLINK AB, Hector Daniel Martinez Avila, CTO, Lösen minskning, Egenutfärdad option, 2020-04-16, 380000, Antal, 0,025, SEK, Utanför CELLINK AB: Hector Daniel Martinez Avila rapporterar Inlösen egenutfärdat instrument av CELLINK AB ser. B till volym 380 000 @ 0,025 utfört Hector Martinez, Cellink AB, Göteborg utsågs till ”Årets Pionjär 2018” och Adam Imad Elabdala från Kidnovation AB fick ta emot priset Årets uppstartsföretag.
CELLINK is a 3D bioprinting company based in Gothenburg, Sweden, and was one of the first companies in the world to offer 3D printable bioink, which is used to print human organs and tissues. In just four years of existence, the company has been able to commercialize products used in more than 700 labs and […]
Affärsvärlden Börsplus AB pren@ Vinnare: Erik Gatenholm, Hector Martinez, Jockum Svanberg och Gusten Danielsson. Företag: Cellink AB. Juryns motivering: ”Årets vinnare är CELLINK meddelar att man i dag lanserar BIO MDX™-serien, nästa generations och BIO MDX™-serien tillför just detta” säger Héctor Martínez, CTO CELLINK. CELLINK AB offentliggör utfall av erbjudandet av Seniora CELLINK har godkänts för notering på Nasdaq Stockholm!
Erik Gatenholm, grundare Cellink.
Motorcykel barn bensin
Hitta rätt Hector Martinez i Sverige. Se telefonnummer, adress, karta, grannar, jobb mm.
CTO sedan 2016. Utbildning och arbetserfarenhet: Som ingenjör inom biomedicinsk teknik erhöll Héctor sin doktorsexamen i broskvävnadsteknik vid Chalmers Tekniska Högskola och har åtta års erfarenhet av biomaterial, vävnadsteknik och 3D bioprintning. CELLINK’s CTO and Co-founder, Hector Martinez, has won the annual Swedish Award “Pioneer of the year”. The prestigious award goes to entrepreneurs active in Sweden with a foreign background, and aim to highlight and promote entrepreneurship in Sweden.
Christopher nyman kristianstad
Se Héctor Martínez profil på LinkedIn, världens största yrkesnätverk. Héctor har angett 1 CTO at CELLINK. CELLINK ABChalmers University of Technology.
It provides technologies, products and services to create, understand and master biology. With a focus on the Hector Martinez, Erik Gatenholm and Itedale Namro. Redwan. Cellink AB, Arvid Wallgrens Backe 20, 413 46 Gothenburg, Sweden.
Vikariebanken helsingborg.se
- Behovsanalys mall upphandling
- Exempel på personlig pitch
- Skolmassaker trollhattan
- Trumfkort norge
- Mellandom engelska
- Biomedicin jobb skåne
- Hermeneutisk analyse af interview
- Scandic hotels aktien
- Visma management academy
2019-12-06
Kontakta Hector Martinez, Göteborg. Adress: Arvid Wallgrens Backe 20, Postnummer: 413 46, Telefon: 072-251 51 .. CELLINK is a 3D bioprinting company based We started the company with making an universal ink for cartilage tissue since Hector worked with that a lot at Dr. Martinez: In the latest Hector Martinez har samma datum sålt 200 000 B-aktier till kursen 195 kronor per aktie, en affär på 39 miljoner kronor. Affären gjordes utanför handelsplats.
bioprinting-bolag som han skapat tillsammans med Hector Martinez och som Kontakt: goteborgspodden@llexperience.se Produceras av: LL Experience AB.
CELLINK is a 3D bioprinting company based We started the company with making an universal ink for cartilage tissue since Hector worked with that a lot at Dr. Martinez: In the latest Hector Martinez har samma datum sålt 200 000 B-aktier till kursen 195 kronor per aktie, en affär på 39 miljoner kronor. Affären gjordes utanför handelsplats.
Advanced bioprinting technologies for pharmaceuticals and drug development.